Orion Biotechnology is Drug Discovery in Canada that focus on Protein Coupled Receptors business. Founded in 2017. They cover business area such as operator, development, precision-engineer GPCR-target therapeutic, its proprietary drug discovery platform, highly potent drug, a set, high-value GPCR target, traditional drug class, novel target, chemokine, healthcare professional, new treatment, serious disease.
2017
( 7 years old in 2024 )
Protein Coupled Receptors
-
343 Preston Street
11th floor
Ottawa, Ontario K1S 1N4
Canada
Private
operatordevelopmentprecision-engineer GPCR-target therapeuticits proprietary drug discovery platformhighly potent druga sethigh-value GPCR targettraditional drug classnovel targetchemokinehealthcare professionalnew treatmentserious disease
* We use standard office opening hours in near Orion Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Orion Biotechnology is Drug Discovery business from Canada that founded in 2017 (7 years old in 2024), Orion Biotechnology business is focusing on Protein Coupled Receptors.
Orion Biotechnology headquarter office and corporate office address is located in 343 Preston Street 11th floor Ottawa, Ontario K1S 1N4 Canada.
Orion Biotechnology was founded in Canada.
In 2024, Orion Biotechnology is currently focus on Protein Coupled Receptors sector.
Above is snippet of Google Trends for "Protein Coupled Receptors" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Orion Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
